The effects of methysergide and cyproheptadine on naloxone-precipitate
d withdrawal symptoms were studied in morphine-dependent mice. The eff
ects of these drugs were investigated both in normal mice and also mic
e injected with 6-OHDA intracerebrally to destroy the central noradren
ergic neurones and examine whether 5-HT mediated effects are somehow l
inked to noradrenergic pathways. Methysergide given 30 min before nalo
xone attenuated withdrawal jumping, ''wet dog'' shakes, burrowing and
body weight loss but aggravated hypothermia. Similar effects were prod
uced by cyproheptadine on withdrawal ''wet dog'' shakes and hypothermi
a. Jumping was aggravated by low doses and attenuated by higher doses
of cyproheptadine. Intracerebral injection of 6-OHDA in 5 days old mic
e pups resulted in hyperlocomotion by the end of 30 days before initia
tion of morphine dependence. When they were made morphine-dependent, m
ice pretreated with 6-OHDA developed higher degree of naloxone-induced
withdrawal jumping than non-treated mice. Methysergide further aggrav
ated jumping but its effect on both ''wet dog'' shakes and burrowing w
as lost in mice exposed to 6-OHDA. These findings suggest that 5-HT re
ceptors are involved in the expression of withdrawal symptoms and the
functional responsiveness of these receptors is dependent on intact no
nadrenergic pathways.